CARBAMYLATION

/ DISEASE & DISORDERS, SCIENCE / By
  1. CARBAMYLATION-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis
  2. CARBAMYLATION and antibodies against carbamylated proteins in autoimmunity and other pathologies
  3. Protein CARBAMYLATION in kidney disease: pathogenesis and clinical implications
  4. Protein CARBAMYLATION and cardiovascular disease
  5. Citrullination and CARBAMYLATION in the pathophysiology of rheumatoid arthritis
  6. Myeloperoxidase-mediated lipoprotein CARBAMYLATION as a mechanistic pathway for atherosclerotic vascular disease
  7. Protein CARBAMYLATION links inflammation, smoking, uremia and atherogenesis
  8. Pitfalls in the detection of citrullination and CARBAMYLATION
  9. Protein CARBAMYLATION: chemistry, pathophysiological involvement, and biomarkers
  10. Protein CARBAMYLATION: in vivo modification or in vitro artefact?
  11. Hemoglobin CARBAMYLATION in uremia
  12. Protein CARBAMYLATION is a hallmark of aging
  13. CARBAMYLATION-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis
  14. CARBAMYLATION of serum albumin as a risk factor for mortality in patients with kidney failure
  15. Protein CARBAMYLATION renders high-density lipoprotein dysfunctional
  16. Protein CARBAMYLATION predicts mortality in ESRD
  17. Photometric method for routine determination of k cat and CARBAMYLATION of rubisco
  18. CARBAMYLATION of Proteins in 2-D Electrophoresis Myth or Reality?
  19. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or CARBAMYLATION: generation of antibodies specific for …
  20. CARBAMYLATION of acetylcholinesterase
  21. Inhibition of protein CARBAMYLATION in urea solution using ammonium-containing buffers
  22. CARBAMYLATION of cysteine: a potential artifact in peptide mapping of hemoglobins in the presence of urea
  23. Myeloperoxidase-derived chlorinating species induce protein CARBAMYLATION through decomposition of thiocyanate and urea: novel pathways generating dysfunctional …
  24. … carboxylase activase levels in tobacco (Nicotiana tabacum) by antisense RNA reduces ribulose bisphosphate carboxylase CARBAMYLATION and impairs photosynthesis
  25. The relationship between CO 2-assimilation rate, Rubisco CARBAMYLATION and Rubisco activase content in activase-deficient transgenic tobacco suggests a simple …
  26. Impaired biological activity of erythropoietin by cyanate CARBAMYLATION
  27. Chronic uremia stimulates LDL CARBAMYLATION and atherosclerosis
  28. Conformational changes induced in bovine lens α-crystallin by CARBAMYLATION. Relevance to cataract
  29. CARBAMYLATION of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis
  30. Impact of CARBAMYLATION on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils
  31. Self‐Assembling Decacyclene Triimides Prepared through a Regioselective Hextuple Friedel–Crafts CARBAMYLATION
  32. Activity ratios of ribulose-1, 5-bisphosphate carboxylase accurately reflect CARBAMYLATION ratios
  33. Nutritional therapy reduces protein CARBAMYLATION through urea lowering in chronic kidney disease
  34. Protein CARBAMYLATION is associated with heart failure and mortality in diabetic patients with end-stage renal disease
  35. Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced CARBAMYLATION; renal failure, smoking …
  36. CARBAMYLATION-induced alterations in low-density lipoprotein metabolism
  37. Plasma protein CARBAMYLATION and decreased acidic drug protein binding in uremia
  38. Protein CARBAMYLATION exacerbates vascular calcification
  39. Structural mechanism of RuBisCO activation by CARBAMYLATION of the active site lysine
  40. CARBAMYLATION of insulin and its biological activity
  41. Aspirin prevents CARBAMYLATION of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: a possible mechanism by which aspirin …
  42. Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: A potential CARBAMYLATION route involved in the formation of atherosclerotic plaques?
  43. Dissociation of enzymatic activity from lethality and pharmacological properties by CARBAMYLATION of lysines in Naja nigricollis and Naja naja atra snake venom …
  44. Factors determining hemoglobin CARBAMYLATION in renal failure
  45. Increased CARBAMYLATION level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function
  46. Is there a link between CARBAMYLATION and citrullination in periodontal disease and rheumatoid arthritis?
  47. Methylation and CARBAMYLATION of human γ‐crystallins
  48. CARBAMYLATION differentially alters type I collagen sensitivity to various collagenases
  49. CARBAMYLATION of lens proteins: a possible factor in cataractogenesis in some tropical countries
  50. CARBAMYLATION promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils
  51. CARBAMYLATION of elastic fibers is a molecular substratum of aortic stiffness
  52. CARBAMYLATION of serum albumin and erythropoietin resistance in end stage kidney disease
  53. Influence of in vivo hemoglobin CARBAMYLATION on HbA1c measurements by various methods
  54. Impact of fibrinogen CARBAMYLATION on fibrin clot formation and stability
  55. Protein CARBAMYLATION in chronic kidney disease and dialysis
  56. Reductions of Rubisco Activase by Antisense RNA in the C4 Plant Flaveria bidentis Reduces Rubisco CARBAMYLATION and Leaf Photosynthesis
  57. Kinetics of the CARBAMYLATION of the amino groups of sickle cell hemoglobin by cyanate
  58. In vivo CARBAMYLATION and acetylation of water‐soluble human lens αB‐crystallin lysine 92
  59. CARBAMYLATION of amino and tyrosine hydroxyl groups: preparation of an inhibitor of oxytocin with no intrinsic activity on the isolated uterus
  60. CARBAMYLATION inhibits the ferroxidase activity of ceruloplasmin
  61. Limitation of the rate of ribulosebisphosphate carboxylase activation by CARBAMYLATION and ribulosebisphosphate carboxylase activase activity: development and tests …
  62. Protein CARBAMYLATION in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes
  63. Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and CARBAMYLATION
  64. CARBAMYLATION is a competitor of glycation for protein modification in vivo
  65. CARBAMYLATION of immunoglobulin abrogates activation of the classical complement pathway
  66. High urea induces depression and LTP impairment through mTOR signalling suppression caused by CARBAMYLATION
  67. CARBAMYLATION of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus
  68. Protein CARBAMYLATION: a marker reflecting increased age-related cell oxidation
  69. Urea and protein CARBAMYLATION in ESRD: surrogate markers or partners in crime?
  70. Mechanism of how CARBAMYLATION reduces albumin binding to FcRn contributing to increased vascular clearance
  71. Protein CARBAMYLATION and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study
  72. Neutrophil-mediated CARBAMYLATION promotes articular damage in rheumatoid arthritis
  73. Improvement of shotgun proteomics in the negative mode by CARBAMYLATION of peptides and ultraviolet photodissociation mass spectrometry
  74. Quantitative estimation of human immunoglobulins following CARBAMYLATION by electrophoresis in antibody-containing agarose
  75. Fractionation of the C-apoproteins from human plasma very low density lipoproteins: artifactual polymorphism from CARBAMYLATION in urea-containing solutions
  76. CARBAMYLATION and binding constants for the inhibition of acetylcholinesterase by physostigmine (eserine)
  77. CARBAMYLATION of proteins and atherogenesis in renal failure
  78. Longitudinal changes in protein CARBAMYLATION and mortality risk after initiation of hemodialysis
  79. PON-1 CARBAMYLATION is enhanced in HDL of uremia patients
  80. Crystal structure of the narrow-spectrum OXA-46 class D β-lactamase: relationship between active-site lysine CARBAMYLATION and inhibition by polycarboxylates
  81. Gas chromatographic studies of the CARBAMYLATION of haemoglobin by methyl isocyanate in rats and rabbits
  82. CARBAMYLATION and glycation compete for collagen molecular aging in vivo
  83. Impact of Posttranslational modification in pathogenesis of rheumatoid arthritis: Focusing on citrullination, CARBAMYLATION, and acetylation
  84. High-molecular-weight crystallin aggregate formation resulting from non-enzymic CARBAMYLATION of lens crystallins: relevance to cataract formation
  85. Protein CARBAMYLATION in ESRD: Is there a mortality effect?
  86. Aspirin prevents the nonenzymatic glycosylation and CARBAMYLATION of the human eye lens crystallins in vitro
  87. Inhibition of 6-phosphogluconate dehydrogenase by CARBAMYLATION and protection by α-crystallin, a chaperone-like protein
  88. Eosinophil peroxidase catalyzed protein CARBAMYLATION participates in asthma
  89. Carbamyl Adducts on Low-Density Lipoprotein Induce IgG Response in LDLR−/− Mice and Bind Plasma Autoantibodies in Humans Under Enhanced CARBAMYLATION
  90. CARBAMYLATION of erythrocyte membrane proteins: an in vitro and in vivo study
  91. Modulation of protein fragmentation through CARBAMYLATION of primary amines
  92. 13 C-CARBAMYLATION as a mechanistic probe for the inhibition of class D β-lactamases by avibactam and halide ions
  93. Impact of CARBAMYLATION and glycation of collagen type I on migration of HT1080 human fibrosarcoma cells
  94. Methylisocyanate and actin polymerization: the in vitro effects of CARBAMYLATION
  95. CARBAMYLATION/citrullination of IgG Fc in bronchiectasis, established RA with bronchiectasis and RA smokers: a potential risk factor for disease
  96. Neutron-encoded protein quantification by peptide CARBAMYLATION
  97. Metabolites related to renal function, immune activation, and CARBAMYLATION are associated with muscle composition in older adults
  98. The effects of parenteral amino acid therapy on protein CARBAMYLATION in maintenance hemodialysis patients
  99. Kinetics of the CARBAMYLATION of cholinesterase
  100. Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell CARBAMYLATION.
  101. CARBAMYLATION of pepsinogen and pepsin
  102. Albumin binding in uraemia: quantitative assessment of inhibition by endogenous ligands and CARBAMYLATION of albumin
  103. Chimeric Arabidopsis thalianaRibulose-1,5-Bisphosphate Carboxylase/Oxygenase Containing a Pea Small Subunit Protein Is Compromised in CARBAMYLATION
  104. The effects of mutation and modification on the structure and stability of human lysozyme: A molecular link between CARBAMYLATION and atherosclerosis
  105. CARBAMYLATION of albumin is a cause for discrepancies between albumin assays
  106. Crystal structures of vertebrate dihydropyrimidinase and complexes from Tetraodon nigroviridis with lysine CARBAMYLATION: metal and structural requirements for post …
  107. Rate constants of CARBAMYLATION and deCARBAMYLATION of acetylcholinesterase for physostigmine and carbaryl in the presence of an oxime
  108. Proatherogenic importance of CARBAMYLATION-induced protein damage and type 2 diabetes mellitus: a systematic review
  109. Protein CARBAMYLATION: a key driver of vascular calcification during chronic kidney disease
  110. Confident Identification of Citrullination and CARBAMYLATION Assisted by Peptide Retention Time Prediction
  111. Parenteral N, N-diethyldithiocarbamate produces segmental demyelination in the rat that is not dependent on cysteine CARBAMYLATION
  112. Inactivation of ribulose-bisphosphate carboxylase by limited proteolysis: loss of the catalytic activity without disruption of bisphosphate binding or CARBAMYLATION
  113. Structure, catalytic mechanism, posttranslational lysine CARBAMYLATION, and inhibition of dihydropyrimidinases
  114. Homocitrulline as marker of protein CARBAMYLATION in hemodialyzed patients
  115. CARBAMYLATION of the chains of hemoglobin S by cyanate in vitro and in vivo
  116. Rates of CARBAMYLATION of specific lysyl residues in bovine alpha-crystallins.
  117. 19F NMR Monitoring of Reversible Protein Post‐Translational Modifications: Class D β‐Lactamase CARBAMYLATION and Inhibition
  118. Rh (III)-Catalyzed Imidoyl C–H CARBAMYLATION and Cyclization to Bicyclic [1, 3, 5] Triazinones
  119. Effect of CARBAMYLATION on protein structure and adsorption to self-assembled monolayer surfaces
  120. CARBAMYLATION of aspartate transaminase and the pK value of the active site lysyl residue.
  121. Hydroxyhomocitrulline is a collagen-specific CARBAMYLATION mark that affects cross-link formation
  122. CARBAMYLATION and affinity constants of some carbamate inhibitors of acetylcholinesterase and their relation to analogous substrate constants
  123. CARBAMYLATION of hemoglobin in renal failure and clinical aspects
  124. Role of cyanate in the induction of vascular dysfunction during uremia: more than protein CARBAMYLATION?
  125. Quantitative CARBAMYLATION as a stable isotopic labeling method for comparative proteomics
  126. Effects of CARBAMYLATION of plasma proteins and competitive displacers on drug binding in uremia
  127. Measurement of Homocitrulline, A CARBAMYLATION‐derived Product, in Serum and Tissues by LC‐MS/MS
  128. Endogenous CARBAMYLATION of renal medullary proteins
  129. Oxime effects on the rate constants of CARBAMYLATION and deCARBAMYLATION of acetylcholinesterase for pyridostigmine, physostigmine and insecticidal carbamates
  130. Regulation of ribulose-1, 5-bisphosphate carboxylase/oxygenase by CARBAMYLATION and 2-carboxyarabinitol 1-phosphate in tobacco: insights from studies of antisense …
  131. Gas chromatographic determination of the CARBAMYLATION of hemoglobin S by cyanate
  132. CARBAMYLATION decreases the cytotoxicity but not the drug-carrier properties of polylysines
  133. CARBAMYLATION of hemoglobin in vivo with chronic sublethal dietary cyanide: implications for hemoglobin S
  134. CARBAMYLATION of Brain Proteins with Cyanate in vitro and in vivo
  135. Homocitrulline formation following CARBAMYLATION of histones with carbamyl phosphate
  136. CARBAMYLATION of human serum albumin generates high-molecular weight aggregates: fine characterization by multi-spectroscopic methods and electron microscopy
  137. CARBAMYLATION of proteins and sulfacetamide free fraction in serum in experimentally-induced high blood urea states.
  138. CARBAMYLATION of erythrocyte membrane aminophospholipids: an in vitro and in vivo study
  139. CO2 CARBAMYLATION of proteins as a mechanism in physiology
  140. Effect of charge on the CARBAMYLATION and binding constants of eel acetylcholinesterase in reaction with neostigmine and related carbamates
  141. The effect of CARBAMYLATION and amidination of rabbit γG-antibody on its ability to fix complement
  142. Autophagy induces protein CARBAMYLATION in fibroblast-like synoviocytes from patients with rheumatoid arthritis
  143. Could cyanogenic glycoside rich diet cause increased risk for CARBAMYLATION-induced protein damage in individuals with chronic inflammatory diseases?
  144. Impact of CARBAMYLATION on three different methods, HPLC, capillary electrophoresis and TINIA of measuring HbA1c levels in patients with kidney disease
  145. Integrating CARBAMYLATION and Ultraviolet Photodissociation Mass Spectrometry for Middle-Down Proteomics
  146. In vitro inhibition of low density lipoprotein CARBAMYLATION by vitamins, as an ameliorating atherosclerotic risk in uremic patients
  147. … physostigmine prevents organophosphate‐induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase CARBAMYLATION
  148. Assigning in vivo CARBAMYLATION and acetylation in human lens proteins using tandem mass spectrometry and database searching
  149. … rapid procedure for simultaneous determinations of hemoglobins A1a, A1b, A1c, F, C, and S, with indication for acetylation or CARBAMYLATION by cation-exchange liquid …
  150. MODIFICATION OF LYSINE 69 REACTIVITY IN BOVINE GROWTH HORMONE BY CARBAMYLATION OF ITS N‐TERMINAL GROUP
  151. Effect of pH, CARBAMYLATION and other hemoglobins on deoxyhemoglobin S aggregation inside intact erythrocytes as detected by proton relaxation rate measurements
  152. CARBAMYLATION of the amino‐terminal residue (Gly1) of mouse serum amyloid A promotes amyloid formation in a cell culture model
  153. GC-NPD and GC-MS analysis of preserved tissue of Bhopal gas disaster: evidence of methyl CARBAMYLATION in post-mortem blood
  154. CARBAMYLATION with cyanate of basic phospholipase A2 from the venom of Naja nigricollis (spitting cobra)
  155. Effect of Sevelamer and Nicotinamide on Albumin CARBAMYLATION in Patients with End-Stage Kidney Disease
  156. Effects of high pressure on the single-turnover kinetics of the CARBAMYLATION of cholinesterase
  157. Charge neutralization of lysine via CARBAMYLATION reveals hidden aggregation hot‐spots in tau protein flanking regions
  158. Some comparative aspects of CARBAMYLATION of human blood and of hemoglobin with cyanate and carbamyl phosphate
  159. Determinants of haemoglobin CARBAMYLATION in haemodialysis and peritoneal dialysis patients
  160. Identification of the primary targets of CARBAMYLATION in bovine lens proteins by mass spectrometry
  161. Structural and functional determinants of Mucor miehei protease: I. Modification of the NH2 terminus and lysine residues by CARBAMYLATION
  162. CARBAMYLATION of antibodies: Investigation of the number of converted amino groups, electrophoretic mobility and immunoprecipitation titre
  163. Redox-mediated CARBAMYLATION as a hapten model applied to the origin of antibodies to modified proteins in rheumatoid arthritis
  164. Decrease in CARBAMYLATION of rubisco by high CO2 concentration is due to decrease of rubisco activase in kidney bean
  165. Crystal structures of monometallic dihydropyrimidinase and the human dihydroorotase domain K1556A mutant reveal no lysine CARBAMYLATION within the active site
  166. … nucleotide linked isocitrate dehydrogenase from bovine heart. I. Studies of an active amino group by amidination, arylation, acetylation, and CARBAMYLATION
  167. Whole salivary immunoglobulin levels in 60 healthy children: determined by a sensitive electroimmuno technique after prior CARBAMYLATION
  168. Preliminary studies of continuous extracorporeal CARBAMYLATION in the treatment of sickle cell anemia.
  169. CARBAMYLATION AND DECARBAMYLATION OF ACETYLCHOLINESTERASE: EFFECT OF CHOLINE, 3, 3‐DIMETHYL‐l‐BUTANOL AND SOME ALLOSTERIC …
  170. CARBAMYLATION of oxytocin and arginine-vasopressin
  171. Microbial O-CARBAMYLATION of novobiocin
  172. Effect of CARBAMYLATION on the molecular recognition action of amino benzothiazole by carrier protein
  173. Quantitative determination of human fibrinogen in plasma following CARBAMYLATION by Laurell electrophoresis in antibody containing gel
  174. Decreased chaperone activity of alpha-crystallin by CARBAMYLATION in vitro
  175. Role of biotin in CARBAMYLATION reactions
  176. ^(13) C Magnetic Resonance Studies of Hemoglobin CARBAMYLATION
  177. CARBAMYLATION of human lens gamma-crystallins: relevance to cataract formation.
  178. Procaine hydrolysis defect in uraemia does not appear to be due to CARBAMYLATION of plasma esterases
  179. CARBAMYLATION of N-terminal proline
  180. Effects of type II collagen epitope CARBAMYLATION and citrullination in human leucocyte antigen (HLA)‐DR4+ monozygotic twins discordant for rheumatoid arthritis
  181. Effect of CARBAMYLATION of lysine ε-amino groups on the activity of blood group specific glycoproteins
  182. Identification of the preferentially targeted proteins by CARBAMYLATION during whole lens incubation by using radio-labelled potassium cyanate and mass …
  183. Impact of albumin CARBAMYLATION on immunoturbidimetric measurement of urinary albumin
  184. CARBAMYLATION and oxidation of proteins lead to apoptotic death of lymphocytes
  185. Mass spectrometric identification of in vivo CARBAMYLATION of the amino terminus of Ectothiorhodospira mobilis high‐potential iron–sulfur protein, isozyme 1
  186. Alkylation and CARBAMYLATION effects of lomustine and its major metabolites and MGMT expression in canine cells
  187. Role of protein CARBAMYLATION in chronic kidney disease complications
  188. CARBAMYLATION reduces the capacity of IgG for hexamerization and complement activation
  189. Fructose 1, 6-bisphosphatase: Dissociation of AMP cooperativity and AMP inhibition by CARBAMYLATION
  190. N-terminal CARBAMYLATION of the hyaluronic acid-binding region and the link protein from the chondrosarcoma proteoglycan aggregate.
  191. Evalution of in vitro effect of flavonoids on human low-density lipoprotein CARBAMYLATION
  192. The effect of triclosan on posttranslational modification of proteins through citrullination and CARBAMYLATION
  193. A sensitive and specific method for quantitative estimation of CARBAMYLATION in proteins
  194. Effects of hexamethonium, phenothiazines, propranolol and ephedrine on acetylcholinesterase CARBAMYLATION by physostigmine, aldicarb and carbaryl: interaction …
  195. CARBAMYLATION and glycosylation of haemoglobin in vitro: effects of cyanate and glucose.
  196. Myocardial oxygen transport during leftward shifts of the oxygen dissociation curve by CARBAMYLATION or hypothermia
  197. The Effect of CARBAMYLATION, Amidination and Benzylation on the Ability of Rabbit γG Antibody to Produce Passive Cutaneous Anaphlaxis in Guinea Pig and Rabbit …
  198. CARBAMYLATION of proteins–mechanism, causes and consequences
  199. Influence of temperature and cholinergic ligands on the CARBAMYLATION of unmodified and carbodiimide-modified erythrocyte acetylcholinesterase
  200. Formation of alkylation and CARBAMYLATION intermediates and cytochrome P-450 catalyzed monooxygenation of the 2-chloroethylnitrosoureas CCNU and Methyl …
  201. The effect of hemoglobin CARBAMYLATION on the survival of human sickle cell erythrocytes in rats.
  202. Increased oxyhemoglobin affinity by CARBAMYLATION: coronary autoregulation and O2 transport
  203. Acylation and CARBAMYLATION of equine muscle carbonic anhydrase (CA-III) upon reaction with p-nitrophenyl esters and carbamoyl phosphate.
  204. Unchanged protein binding of penbutolol in renal insufficiency: a possible role of CARBAMYLATION.
  205. Protein CARBAMYLATION is a physiological post‐translational modification in the renal inner medulla
  206. Protein CARBAMYLATION in peritoneal dialysis and the effect of low glucose plus amino acid solutions
  207. CARBAMYLATION OF ALKALINE MESENTERICOPEPTIDASE
  208. CARBAMYLATION distributions in extracorporeal treatment of sickle cell anemia
  209. The Research of E. Coli’s Chlioacillus CARBAMYLATION Dispersing D, L-Met
  210. The effects of CARBAMYLATION of hormones on their biological activities–with reference to 3, 5, 3′-L-triiodothyronine and insulin
  211. Effect of Cyanate on the CARBAMYLATION and Biological Activity of Superoxide Dismutase
  212. CARBAMYLATION of human HbF on carboxy methyl cellulose column in 8 M urea pH 6.7
  213. Changes in lymphocyte properties after employment of the combination of CARBAMYLATION and oxidative stress, an in vitro study
  214. His267 is involved in CARBAMYLATION and catalysis of RuBisCO-like protein from Bacillus subtilis
  215. CARBAMYLATION of normal and uremic erythrocyte membrane protein
  216. SaO021 Platelets in the Uremic Milieu-Exploring the Link between Protein CARBAMYLATION and Platelet Dysfunction in ESRD
  217. Optimization of CARBAMYLATION conditions and study on the effects on the product ions of CARBAMYLATION and dual modification of the peptide by Q-TOF MS
  218. Myeloperoxidase Catalyzed Protein CARBAMYLATION: A Mechanism Linking Smoking, Inflammation And Atherogenesis
  219. CARBAMYLATION, CHRONIC INFLAMMATORY STATUS, AND OXIDATIVE STRESS IN CHRONIC RENAL DISEASE: Promoting Factors of Carcinogenesis
  220. Protein CARBAMYLATION links uremia, inflammation, and atherogenesis
  221. A coupled spectrophotometric assay for routine assessment of CARBAMYLATION and kcat of rubisco
  222. Effect of length and CARBAMYLATION on aggregation of A? derived aggregation-prone peptides
  223. Investigating the aggregation behavior of tau microtubule binding region (V306-F378) and the effect of CARBAMYLATION on this aggregation
  224. Effects of type II collagen epitope CARBAMYLATION and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis
  225. CARBAMYLATION of erythrocyte membrane components: An in vitro and in vivo study.
  226. FRI0354 Effects of CARBAMYLATION and Citrullination of B and T Epitopes of Human Type II Collagen on Lymphocytes from Dr4+ Monozygotic Twins Discordant for …
  227. The ‘Senshu’method often used to detect citrullinated proteins does not discriminate between citrullination and CARBAMYLATION
  228. The CARBAMYLATION of proteins leads to alterations in the membrane structure of erythrocytes
  229. Protein CARBAMYLATION exacerbates vascular calcification
  230. Development of a method for the investigation of protein CARBAMYLATION by CO2
  231. CARBAMYLATION of Proteins and Sulfacetamide Free Fraction in Serum in Experimentally-Induced High Blood Urea States
  232. Analysis of CARBAMYLATION and acetylation of lens proteins

 

Related Posts

Shopping Cart
Scroll to Top